ETF Home ETF List Shorted Stocks Home About

Portfolio Holdings Detail for ISIN IE00B3VWM098
Stock Name / FundiShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
IssuerBlackrock
Entity holding fund iShares VII Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300Q7FFITMZ2PFZ28
ETF TickerCUS1(GBX) LSE
ETF TickerCUSS(USD) LSE
ETF TickerSXRG(EUR) F
ETF TickerCSUSS.MI(EUR) CXE
ETF TickerCSUSSz(USD) CXE
ETF TickerCUSS.LS(USD) CXE
ETF TickerCSUSS(EUR) ETF Plus
ETF TickerCUS1.L(GBP) LSE
ETF TickerCUSS.L(GBP) LSE

Holdings detail for AMPH

Stock NameAmphastar P
TickerAMPH(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS03209R1032
LEI54930055TH0ZLSAQMJ38

Show aggregate AMPH holdings

News associated with AMPH

Amphastar Pharmaceuticals (NASDAQ:AMPH) Given New $32.00 Price Target at Bank of America
Amphastar Pharmaceuticals (NASDAQ:AMPH – Free Report) had its target price upped by Bank of America from $28.00 to $32.00 in a research report report published on Tuesday,Benzinga reports. They currently have a neutral rating on the stock. Several other research firms also recently weighed in on AMPH. JPMorgan Chase & Co. reissued a “neutral” rating […] - 2025-08-27 02:52:54
Amphastar Pharmaceuticals (NASDAQ:AMPH) vs. Personalis (NASDAQ:PSNL) Financial Contrast
Amphastar Pharmaceuticals (NASDAQ:AMPH – Get Free Report) and Personalis (NASDAQ:PSNL – Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, risk, dividends, valuation and earnings. Volatility and Risk Amphastar Pharmaceuticals has a beta […] - 2025-08-20 02:55:13
Piper Sandler Cuts Amphastar Pharmaceuticals (NASDAQ:AMPH) Price Target to $25.00
Amphastar Pharmaceuticals (NASDAQ:AMPH – Free Report) had its price target trimmed by Piper Sandler from $30.00 to $25.00 in a report issued on Friday morning,Benzinga reports. The brokerage currently has a neutral rating on the stock. Other analysts have also issued reports about the stock. Needham & Company LLC reissued a “hold” rating on shares […] - 2025-08-11 03:08:44
The Math Shows IJS Can Go To $119
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-08-07 08:57:20
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Stake Raised by Victory Capital Management Inc.
Victory Capital Management Inc. grew its stake in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 27.9% in the first quarter, Holdings Channel.com reports. The fund owned 81,087 shares of the company’s stock after buying an additional 17,700 shares during the quarter. Victory Capital Management Inc.’s holdings in Amphastar Pharmaceuticals were worth $2,351,000 […] - 2025-07-29 04:20:54
New York State Common Retirement Fund Acquires 11,075 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)
New York State Common Retirement Fund lifted its stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 15.7% in the 1st quarter, HoldingsChannel reports. The institutional investor owned 81,565 shares of the company’s stock after purchasing an additional 11,075 shares during the quarter. New York State Common Retirement Fund’s holdings in Amphastar Pharmaceuticals were […] - 2025-07-24 04:40:46
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Sells 493,214 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lessened its holdings in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 85.6% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 83,231 shares of the company’s […] - 2025-06-06 04:42:49
Squarepoint Ops LLC Buys 11,929 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)
Squarepoint Ops LLC grew its stake in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 208.0% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 17,664 shares of the company’s stock after purchasing an additional 11,929 shares during the period. Squarepoint Ops […] - 2025-06-03 05:38:56
Nuveen Asset Management LLC Sells 112,307 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)
Nuveen Asset Management LLC trimmed its position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 54.0% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 95,665 shares of the company’s stock after selling 112,307 shares during the quarter. Nuveen Asset Management LLC’s holdings […] - 2025-06-02 05:04:53
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Sold by Two Sigma Investments LP
Two Sigma Investments LP lowered its position in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 0.6% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 98,184 shares of the company’s stock after selling 614 shares during the quarter. Two Sigma Investments LP’s holdings in Amphastar Pharmaceuticals were worth $3,646,000 as of […] - 2025-05-29 05:14:54
Two Sigma Advisers LP Sells 12,400 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)
Two Sigma Advisers LP lessened its position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 12.6% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 85,900 shares of the company’s stock after selling 12,400 shares during the period. Two Sigma Advisers LP’s holdings in Amphastar Pharmaceuticals were worth $3,189,000 as of its most […] - 2025-05-27 05:57:02
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Sold by The Manufacturers Life Insurance Company
The Manufacturers Life Insurance Company trimmed its stake in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 2.8% in the 4th quarter, HoldingsChannel reports. The firm owned 21,257 shares of the company’s stock after selling 610 shares during the period. The Manufacturers Life Insurance Company’s holdings in Amphastar Pharmaceuticals were worth $789,000 as […] - 2025-05-15 04:45:07
Northern Trust Corp Purchases 29,808 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)
Northern Trust Corp raised its position in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 5.1% in the fourth quarter, HoldingsChannel reports. The firm owned 613,170 shares of the company’s stock after acquiring an additional 29,808 shares during the period. Northern Trust Corp’s holdings in Amphastar Pharmaceuticals were worth $22,767,000 as of its […] - 2025-05-13 05:28:51
Hsbc Holdings PLC Boosts Stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)
Hsbc Holdings PLC lifted its holdings in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 23.4% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 8,991 shares of the company’s stock after purchasing an additional 1,707 shares during the quarter. […] - 2025-05-09 05:41:01
Analysts Forecast 23% Gains Ahead For IJT
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-05-05 08:57:34
First Trust Advisors LP Raises Stock Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)
First Trust Advisors LP boosted its stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 350.0% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 81,129 shares of the company’s stock after purchasing an additional 63,100 shares during the quarter. […] - 2025-05-04 05:30:50
Barclays PLC Acquires 10,334 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)
Barclays PLC lifted its holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 13.9% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 84,790 shares of the company’s stock after acquiring an additional 10,334 shares during the period. Barclays PLC’s holdings […] - 2025-04-30 05:12:50
Raymond James Financial Inc. Invests $3.45 Million in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)
Raymond James Financial Inc. purchased a new stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 92,904 shares of the company’s stock, valued at approximately $3,450,000. Raymond James Financial Inc. owned approximately 0.19% of Amphastar […] - 2025-04-28 05:06:47
Vanguard Group Inc. Has $100.79 Million Stock Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)
Vanguard Group Inc. increased its stake in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 0.1% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 2,714,628 shares of the company’s stock after acquiring an additional 3,155 shares during the quarter. Vanguard Group Inc. owned 0.06% of Amphastar Pharmaceuticals worth $100,794,000 as of […] - 2025-04-10 04:38:49
American Century Companies Inc. Decreases Stock Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)
American Century Companies Inc. lessened its holdings in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 26.2% in the fourth quarter, Holdings Channel.com reports. The fund owned 472,017 shares of the company’s stock after selling 167,575 shares during the period. American Century Companies Inc.’s holdings in Amphastar Pharmaceuticals were worth $17,526,000 at the […] - 2025-04-01 05:38:53
Thrivent Financial for Lutherans Cuts Stock Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)
Thrivent Financial for Lutherans reduced its stake in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 2.8% during the fourth quarter, Holdings Channel reports. The institutional investor owned 28,988 shares of the company’s stock after selling 827 shares during the quarter. Thrivent Financial for Lutherans’ holdings in Amphastar Pharmaceuticals were worth $1,076,000 at […] - 2025-04-01 04:40:47
Victory Capital Management Inc. Sells 155,144 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)
Victory Capital Management Inc. cut its stake in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 71.0% in the 4th quarter, Holdings Channel.com reports. The fund owned 63,387 shares of the company’s stock after selling 155,144 shares during the period. Victory Capital Management Inc.’s holdings in Amphastar Pharmaceuticals were worth $2,354,000 as of […] - 2025-03-18 05:41:08
AlphaQuest LLC Reduces Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)
AlphaQuest LLC reduced its holdings in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 35.9% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 4,862 shares of the company’s stock after selling 2,724 shares during the period. AlphaQuest […] - 2025-03-17 06:03:06
Smartleaf Asset Management LLC Buys 493 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)
Smartleaf Asset Management LLC grew its stake in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 222.1% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 715 shares of the company’s stock after purchasing an additional 493 shares during the quarter. Smartleaf Asset Management LLC’s holdings in Amphastar Pharmaceuticals were worth $26,000 […] - 2025-03-13 05:54:49
Assetmark Inc. Decreases Stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)
Assetmark Inc. reduced its stake in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 4.5% during the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 41,921 shares of the company’s stock after selling 1,985 shares during the period. Assetmark Inc.’s holdings in Amphastar Pharmaceuticals were […] - 2025-03-11 06:20:51
Amphastar Pharmaceuticals (NASDAQ:AMPH) Lowered to “Neutral” Rating by Piper Sandler
Piper Sandler cut shares of Amphastar Pharmaceuticals (NASDAQ:AMPH – Free Report) from an overweight rating to a neutral rating in a research note issued to investors on Tuesday, Marketbeat reports. They currently have $36.00 price target on the stock, down from their previous price target of $66.00. A number of other equities research analysts also […] - 2025-02-05 06:38:50

iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc AMPH holdings

DateNumber of AMPH Shares HeldBase Market Value of AMPH SharesLocal Market Value of AMPH SharesChange in AMPH Shares HeldChange in AMPH Base ValueCurrent Price per AMPH Share HeldPrevious Price per AMPH Share Held
2025-12-11 (Thursday)4,003USD 103,678AMPH holding increased by 761USD 103,6780USD 761 USD 25.9001 USD 25.71
2025-12-10 (Wednesday)4,003USD 102,917AMPH holding increased by 240USD 102,9170USD 240 USD 25.71 USD 25.65
2025-12-09 (Tuesday)4,003USD 102,677AMPH holding decreased by -1441USD 102,6770USD -1,441 USD 25.65 USD 26.01
2025-12-08 (Monday)4,003USD 104,118AMPH holding decreased by -3042USD 104,1180USD -3,042 USD 26.01 USD 26.7699
2025-12-05 (Friday)4,003USD 107,160AMPH holding decreased by -1521USD 107,1600USD -1,521 USD 26.7699 USD 27.1499
2025-12-04 (Thursday)4,003USD 108,681AMPH holding decreased by -1722USD 108,6810USD -1,722 USD 27.1499 USD 27.5801
2025-12-03 (Wednesday)4,003AMPH holding decreased by -70USD 110,403AMPH holding increased by 1776USD 110,403-70USD 1,776 USD 27.5801 USD 26.67
2025-12-02 (Tuesday)4,073AMPH holding increased by 28USD 108,627AMPH holding decreased by -2408USD 108,62728USD -2,408 USD 26.67 USD 27.4499
2025-12-01 (Monday)4,045USD 111,035AMPH holding decreased by -1012USD 111,0350USD -1,012 USD 27.4499 USD 27.7001
2025-11-28 (Friday)4,045USD 112,047AMPH holding increased by 1376USD 112,0470USD 1,376 USD 27.7001 USD 27.36
2025-11-27 (Thursday)4,045USD 110,671USD 110,6710USD 0 USD 27.36 USD 27.36
2025-11-26 (Wednesday)4,045USD 110,671AMPH holding decreased by -1335USD 110,6710USD -1,335 USD 27.36 USD 27.69
2025-11-25 (Tuesday)4,045AMPH holding decreased by -42USD 112,006AMPH holding increased by 2842USD 112,006-42USD 2,842 USD 27.69 USD 26.7101
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of AMPH by Blackrock for IE00B3VWM098

Show aggregate share trades of AMPH

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-12-03SELL-7027.82026.750 26.857USD -1,880 29.76 Profit of 203 on sale
2025-12-02BUY2827.62026.230 26.369USD 738 29.77
2025-11-25SELL-4227.76026.900 26.986USD -1,133 29.82 Profit of 119 on sale
2025-11-24SELL-4226.79025.960 26.043USD -1,094 29.84 Profit of 159 on sale
2025-11-17SELL-15426.54025.690 25.775USD -3,969 29.94 Profit of 642 on sale
2025-11-12SELL-1428.89027.120 27.297USD -382 29.99 Profit of 38 on sale
2025-11-06SELL-1425.53024.150 24.288USD -340 30.09 Profit of 81 on sale
2025-11-05SELL-14025.65025.070 25.128USD -3,518 30.11 Profit of 698 on sale
2025-11-04SELL-2825.40024.926 24.973USD -699 30.14 Profit of 145 on sale
2025-11-03SELL-2825.85424.900 24.995USD -700 30.16 Profit of 145 on sale
2025-10-28BUY4224.18024.450 24.423USD 1,026 30.28
2025-10-24SELL-1424.52024.890 24.853USD -348 30.35 Profit of 77 on sale
2025-10-15BUY8423.14024.200 24.094USD 2,024 30.60
2025-10-02BUY1426.52027.030 26.979USD 378 30.65
2025-09-30BUY2826.65027.270 27.208USD 762 30.69
2025-08-21SELL-1429.66030.420 30.344USD -425 30.79 Profit of 6 on sale
2025-07-31BUY4220.95021.330 21.292USD 894 30.86
2025-06-30SELL-2822.96023.250 23.221USD -650 31.97 Profit of 245 on sale
2025-06-25SELL-1423.45024.530 24.422USD -342 32.16 Profit of 108 on sale
2025-06-20SELL-2824.56025.850 25.721USD -720 32.32 Profit of 185 on sale
2025-05-23BUY1424.47024.490 24.488USD 343 33.41
2025-05-19SELL-1424.79024.930 24.916USD -349 33.71 Profit of 123 on sale
2025-05-15SELL-4224.32024.700 24.662USD -1,036 33.87 Profit of 387 on sale
2025-05-12SELL-1424.34024.570 24.547USD -344 34.14 Profit of 134 on sale
2025-05-09SELL-1424.11025.030 24.938USD -349 34.23 Profit of 130 on sale
2025-04-30SELL-1424.41024.520 24.509USD -343 34.89 Profit of 145 on sale
2025-04-24SELL-2824.07024.150 24.142USD -676 35.32 Profit of 313 on sale
2025-04-17SELL-1423.35023.620 23.593USD -330 35.94 Profit of 173 on sale
2025-04-15SELL-4223.50024.920 24.778USD -1,041 36.21 Profit of 480 on sale
2025-04-14SELL-4224.42024.770 24.735USD -1,039 36.34 Profit of 487 on sale
2025-04-09SELL-5625.23025.510 25.482USD -1,427 36.74 Profit of 631 on sale
2025-04-07SELL-9825.00025.950 25.855USD -2,534 37.03 Profit of 1,095 on sale
2025-04-04SELL-14026.61027.020 26.979USD -3,777 37.15 Profit of 1,424 on sale
2025-03-31BUY1428.99029.180 29.161USD 408 37.47
2025-03-19SELL-2827.86027.870 27.869USD -780 38.45 Profit of 296 on sale
2025-03-14SELL-8426.66026.760 26.750USD -2,247 38.91 Profit of 1,022 on sale
2025-03-13SELL-2826.24026.860 26.798USD -750 39.09 Profit of 344 on sale
2025-03-12SELL-47626.28027.550 27.423USD -13,053 39.28 Profit of 5,642 on sale
2025-03-07SELL-2828.81029.370 29.314USD -821 39.77 Profit of 293 on sale
2025-03-06SELL-4228.32028.490 28.473USD -1,196 39.95 Profit of 482 on sale
2025-03-03SELL-1427.52029.100 28.942USD -405 40.53 Profit of 162 on sale
2025-02-28SELL-8428.43031.000 30.743USD -2,582 40.72 Profit of 838 on sale
2025-02-26SELL-1431.21032.220 32.119USD -450 41.03 Profit of 125 on sale
2025-02-25SELL-4231.99032.560 32.503USD -1,365 41.19 Profit of 365 on sale
2025-02-18BUY7030.75031.650 31.560USD 2,209 42.30
2025-02-13BUY1431.74031.950 31.929USD 447 42.97
2025-02-12BUY1431.82032.400 32.342USD 453 43.19
2025-02-11BUY4232.21032.250 32.246USD 1,354 43.42
2025-02-06BUY12632.79033.420 33.357USD 4,203 44.15
2025-01-27BUY1437.11037.660 37.605USD 526 46.10
2024-12-30BUY7036.84037.690 37.605USD 2,632 47.26
2024-12-06BUY5643.80044.270 44.223USD 2,476 47.61
2024-12-05BUY1443.60044.270 44.203USD 619 47.75
2024-12-04BUY7044.30045.240 45.146USD 3,160 47.87
2024-11-29BUY7045.19045.550 45.514USD 3,186 48.17
2024-11-27BUY5645.21045.710 45.660USD 2,557 48.43
2024-11-26BUY1444.22044.880 44.814USD 627 48.62
2024-11-21BUY7044.55044.710 44.694USD 3,129 49.21
2024-11-20BUY4244.09044.540 44.495USD 1,869 49.50
2024-11-18BUY16844.16044.860 44.790USD 7,525 50.20
2024-11-12BUY11247.71049.120 48.979USD 5,486 50.37
2024-11-08BUY7048.31049.530 49.408USD 3,459 50.51
2024-11-07BUY21046.09049.450 49.114USD 10,314 50.85
2024-11-06BUY2853.40053.960 53.904USD 1,509 50.64
2024-10-31BUY1450.53051.350 51.268USD 718 50.54
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of AMPH

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-1955,7460114,92048.5%
2025-09-1889,1750173,57151.4%
2025-09-17443,2390520,39685.2%
2025-09-16111,9160181,52361.7%
2025-09-1573,0070149,65948.8%
2025-09-1243,242096,38444.9%
2025-09-1154,5986115,30547.4%
2025-09-1052,436097,93653.5%
2025-09-0977,3480171,12845.2%
2025-09-0872,8770141,50951.5%
2025-09-0591,062191167,75754.3%
2025-09-04157,7220260,18960.6%
2025-09-0381,10870186,89643.4%
2025-09-02100,2460148,26767.6%
2025-08-2962,5880116,35653.8%
2025-08-2837,1620118,42331.4%
2025-08-2754,0390103,85952.0%
2025-08-2656,8170129,49243.9%
2025-08-2546,8980143,08232.8%
2025-08-2264,0100166,91638.3%
2025-08-2169,7450185,49137.6%
2025-08-2063,19669138,13145.8%
2025-08-19122,54733187,47765.4%
2025-08-1870,958250167,86942.3%
2025-08-15166,0260240,16069.1%
2025-08-1499,05917175,55456.4%
2025-08-13218,96929,560374,49158.5%
2025-08-12405,1060607,75166.7%
2025-08-11340,1394,251644,08052.8%
2025-08-08168,545281406,78741.4%
2025-08-07168,5310307,60454.8%
2025-08-0678,93521144,12754.8%
2025-08-0547,0660138,56934.0%
2025-08-0467,6800152,92444.3%
2025-08-0191,4140174,78952.3%
2025-07-31109,0030200,47254.4%
2025-07-3045,1890124,57936.3%
2025-07-2984,9951,699128,55766.1%
2025-07-28101,4360189,51753.5%
2025-07-2534,1290120,02428.4%
2025-07-2432,423097,43433.3%
2025-07-23102,1100207,04649.3%
2025-07-2273,751567161,84245.6%
2025-07-2189,9920161,38755.8%
2025-07-1870,0010152,26246.0%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Copyright Market Footprint Ltd. Privacy Policy